Titan Biotech Limited (TITANBIO.BO)

INR 781.0

(1.07%)

Total Debt Summary of Titan Biotech Limited

Titan Biotech Limited's latest annual total debt in 2023 was 83.02 Million INR , down -2.45% from previous year.
Titan Biotech Limited's latest quarterly total debt in 2023 FY was 83.02 Million INR , down -2.45% from previous quarter.
Titan Biotech Limited reported annual total debt of 85.11 Million INR in 2022, down -58.67% from previous year.
Titan Biotech Limited reported annual total debt of 205.94 Million INR in 2021, up 39.26% from previous year.
Titan Biotech Limited reported quarterly total debt of 85.64 Million INR for 2023 Q2, down 0.0% from previous quarter.
Titan Biotech Limited reported quarterly total debt of 83.02 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Titan Biotech Limited (2023 - 2008)

Historical Annual Total Debt of Titan Biotech Limited (2023 - 2008)

Year	Total Debt	Total Debt Growth
2023	83.02 Million INR	-2.45%
2022	85.11 Million INR	-58.67%
2021	205.94 Million INR	39.26%
2020	147.88 Million INR	-38.06%
2019	238.74 Million INR	0.95%
2018	236.49 Million INR	-8.24%
2017	257.74 Million INR	14.78%
2016	224.55 Million INR	96.82%
2015	114.09 Million INR	47.96%
2014	77.1 Million INR	10.35%
2013	69.87 Million INR	95.1%
2012	35.81 Million INR	108.7%
2011	17.16 Million INR	-37.25%
2010	27.35 Million INR	113.32%
2009	12.82 Million INR	158.0%
2008	4.96 Million INR	0.0%

Year	Total Debt	Total Debt Growth
2023 Q3	- INR	-100.0%
2023 Q2	85.64 Million INR	0.0%
2023 Q4	83.02 Million INR	0.0%
2023 FY	83.02 Million INR	-2.45%
2023 Q1	- INR	-100.0%
2022 Q4	85.11 Million INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	73.34 Million INR	53.85%
2022 Q1	47.67 Million INR	-76.85%
2022 FY	85.11 Million INR	-58.67%
2021 Q2	130.75 Million INR	-21.06%
2021 Q1	165.64 Million INR	12.01%
2021 FY	205.94 Million INR	39.26%
2021 Q4	205.94 Million INR	12.5%
2021 Q3	183.06 Million INR	40.0%
2020 Q1	229.61 Million INR	-3.83%
2020 Q3	115.59 Million INR	-40.97%
2020 FY	147.88 Million INR	-38.06%
2020 Q4	147.88 Million INR	27.94%
2020 Q2	195.82 Million INR	-14.71%
2019 Q2	222.44 Million INR	0.0%
2019 FY	238.74 Million INR	0.95%
2019 Q4	238.74 Million INR	0.0%
2018 Q2	245.43 Million INR	0.0%
2018 FY	236.49 Million INR	-8.24%
2018 Q4	236.49 Million INR	0.0%
2017 Q4	257.74 Million INR	0.0%
2017 FY	257.74 Million INR	14.78%
2017 Q2	228.4 Million INR	0.0%
2016 Q2	111.48 Million INR	0.0%
2016 FY	224.55 Million INR	96.82%
2016 Q4	224.55 Million INR	0.0%
2015 Q4	114.09 Million INR	0.0%
2015 Q2	60.78 Million INR	0.0%
2015 FY	114.09 Million INR	47.96%
2014 Q4	77.1 Million INR	0.0%
2014 FY	77.1 Million INR	10.35%
2013 FY	69.87 Million INR	95.1%
2013 Q2	26.4 Million INR	0.0%
2013 Q4	69.87 Million INR	0.0%
2012 Q4	35.81 Million INR	0.0%
2012 FY	35.81 Million INR	108.7%
2011 FY	17.16 Million INR	-37.25%
2011 Q4	17.16 Million INR	0.0%
2010 FY	27.35 Million INR	113.32%
2010 Q4	27.35 Million INR	0.0%
2009 FY	12.82 Million INR	158.0%
2008 FY	4.96 Million INR	0.0%
2008 Q4	4.96 Million INR	0.0%

Peer Total Debt Comparison of Titan Biotech Limited

Name	Total Debt	Total Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	93.879%
Biocon Limited	162.76 Billion INR	99.949%
Blue Jet Healthcare Limited	16.12 Million INR	-414.749%
Concord Biotech Limited	97.37 Million INR	14.734%
Dishman Carbogen Amcis Limited	23.12 Billion INR	99.641%
FERMENTA BIOTECH LIMITED	1.32 Billion INR	93.723%
GENOMIC VALLEY BIOTECH LIMITED	- INR	-Infinity%
Lyka Labs Limited	586.5 Million INR	85.843%
Panacea Biotec Limited	209.9 Million INR	60.444%
SAMSRITA LABS LIMITED	22.03 Million INR	-276.856%
Servoteach Industries Limited	5059.00 INR	-1641113.679%
SMS Lifesciences India Limited	1 Billion INR	91.757%
Supriya Lifescience Limited	54.88 Million INR	-51.292%
Syngene International Limited	5.55 Billion INR	98.505%
TAKE Solutions Limited	370.85 Million INR	77.611%
Transgene Biotek Limited	140.01 Million INR	40.698%
Vanta Bioscience Limited	609.53 Million INR	86.378%